Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1994 3
1995 1
1996 4
1997 2
1998 6
1999 2
2000 2
2001 2
2002 2
2003 2
2004 1
2005 1
2006 2
2007 4
2008 3
2009 3
2010 3
2011 2
2012 6
2013 2
2014 3
2015 5
2016 4
2017 2
2018 4
2019 1
2020 2
2021 2
2022 1
2023 2
2024 1
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Management of Menopausal Symptoms: A Review.
Crandall CJ, Mehta JM, Manson JE. Crandall CJ, et al. JAMA. 2023 Feb 7;329(5):405-420. doi: 10.1001/jama.2022.24140. JAMA. 2023. PMID: 36749328 Review.
Oral and transdermal estrogen have similar efficacy. Conjugated equine estrogens (CEE) with or without medroxyprogesterone acetate (MPA) were the only hormonal treatments for which clinical trials were designed to examine cardiovascular events, venous
Oral and transdermal estrogen have similar efficacy. Conjugated equine estrogens (CEE) with or without medroxypr
The Art of Hormone Replacement Therapy (HRT) in Menopause Management.
Cameron CR, Cohen S, Sewell K, Lee M. Cameron CR, et al. J Pharm Pract. 2024 Jun;37(3):736-740. doi: 10.1177/08971900231167925. Epub 2023 Apr 1. J Pharm Pract. 2024. PMID: 37002679 Review.
There are several nuances to prescribing HRT that can make doing so complex. These include consideration of cyclic vs continuous administration and of tapering therapy. Additionally, estrogen is available in a variety of dosage forms including injections and …
There are several nuances to prescribing HRT that can make doing so complex. These include consideration of cyclic vs continuous a
Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis.
Mohammed K, Abu Dabrh AM, Benkhadra K, Al Nofal A, Carranza Leon BG, Prokop LJ, Montori VM, Faubion SS, Murad MH. Mohammed K, et al. J Clin Endocrinol Metab. 2015 Nov;100(11):4012-20. doi: 10.1210/jc.2015-2237. J Clin Endocrinol Metab. 2015. PMID: 26544651
OBJECTIVE: The objective was to synthesize the evidence about the risk of vascular events in postmenopausal women who use oral estrogen therapy (ET) and transdermal ET. METHODS: We searched bibliographical databases through August 2013 for longitudinal compar …
OBJECTIVE: The objective was to synthesize the evidence about the risk of vascular events in postmenopausal women who use oral est
Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.
Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Xia K, Schmidt PJ, Girdler SS. Gordon JL, et al. JAMA Psychiatry. 2018 Feb 1;75(2):149-157. doi: 10.1001/jamapsychiatry.2017.3998. JAMA Psychiatry. 2018. PMID: 29322164 Free PMC article. Clinical Trial.
Participants included euthymic perimenopausal and early postmenopausal women from the community, aged 45 to 60 years. INTERVENTIONS: Transdermal estradiol (0.1 mg/d) or transdermal placebo for 12 months. Oral micronized progesterone (200 mg/d for 12 days) was …
Participants included euthymic perimenopausal and early postmenopausal women from the community, aged 45 to 60 years. INTERVENTIONS: Tran
Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
Taylor HS, Tal A, Pal L, Li F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Du W, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Neal-Perry G, Santoro NF, Harman SM. Taylor HS, et al. JAMA Intern Med. 2017 Oct 1;177(10):1471-1479. doi: 10.1001/jamainternmed.2017.3877. JAMA Intern Med. 2017. PMID: 28846767 Free PMC article.
IMPORTANCE: Sexual dysfunction, an important determinant of women's health and quality of life, is commonly associated with declining estrogen levels around the menopausal transition. OBJECTIVE: To determine the effects of oral or transdermal estrog
IMPORTANCE: Sexual dysfunction, an important determinant of women's health and quality of life, is commonly associated with declining est
Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B, Pressman A, Bradley C. Ettinger B, et al. Menopause. 1998 Fall;5(3):152-6. Menopause. 1998. PMID: 9774760
PATIENTS: Women aged > or = 45 years who filled index prescriptions for HRT during 1995 for either 0.05 mg transdermal estradiol semiweekly or 0.625 mg oral conjugated estrogen daily. All had filled prescriptions for medroxyprogesterone acetate (MPA) on th …
PATIENTS: Women aged > or = 45 years who filled index prescriptions for HRT during 1995 for either 0.05 mg transdermal estradiol s …
A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
Chu MC, Cosper P, Nakhuda GS, Lobo RA. Chu MC, et al. Fertil Steril. 2006 Dec;86(6):1669-75. doi: 10.1016/j.fertnstert.2006.04.043. Epub 2006 Oct 30. Fertil Steril. 2006. PMID: 17074346 Free article. Clinical Trial.
OBJECTIVE: To determine whether it would be preferable to prescribe oral or transdermal estrogen to symptomatic postmenopausal women with metabolic syndrome (MBS). ...CONCLUSION(S): This short-term study suggests that oral E(2) may worsen IR and adipoc …
OBJECTIVE: To determine whether it would be preferable to prescribe oral or transdermal estrogen to symptomatic postmen …
Considerations in the choice of oral vs. transdermal hormone therapy: a review.
Minkin MJ. Minkin MJ. J Reprod Med. 2004 Apr;49(4):311-20. J Reprod Med. 2004. PMID: 15134159 Review.
This same profile was not seen in the estrogen-only arm of the study, and the trial investigators cautioned that the results observed with CEE/MPA might not apply to other dosages of combined hormone therapy, other types of estrogens and progestins, or other routes …
This same profile was not seen in the estrogen-only arm of the study, and the trial investigators cautioned that the results observed …
Impact of route of administration on genotoxic oestrogens concentrations using oral vs transdermal oestradiol in girls with Turner syndrome.
Mauras N, Torres-Santiago L, Santen R, Mericq V, Ross J, Colon-Otero G, Damaso L, Hossain J, Wang Q, Mesaros C, Blair IA. Mauras N, et al. Clin Endocrinol (Oxf). 2019 Jan;90(1):155-161. doi: 10.1111/cen.13869. Epub 2018 Oct 25. Clin Endocrinol (Oxf). 2019. PMID: 30281805 Clinical Trial.
Also, higher after oral treatment were catechol-oestrogens 4-hydroxy-E(2) (149 vs 28 [ 49] pmol/L), 2-hydroxy-E(2) (300 vs 76 [ 52]), 4-hydroxy-E(1) (450 vs 105 [ 113]), 2-hydroxy-E(1) (3094 vs 740 [ 684]) and 16alpha-hydroxy-E(1) (3,007 …
Also, higher after oral treatment were catechol-oestrogens 4-hydroxy-E(2) (149 vs 28 [ 49] pmol/L), 2-hydroxy-E(2) (300 …
Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR. Bellantoni MF, et al. J Clin Endocrinol Metab. 1996 Aug;81(8):2848-53. doi: 10.1210/jcem.81.8.8768841. J Clin Endocrinol Metab. 1996. PMID: 8768841 Clinical Trial.
To compare the effects of oral vs. transdermal estrogens on GH secretion and levels of circulating insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) in younger vs. older postmenopausal women, we conducted a placebo-control …
To compare the effects of oral vs. transdermal estrogens on GH secretion and levels of circulating insulin-like …
77 results